DrugDev
IQVIA is a global leader in healthcare intelligence, technology, and clinical research solutions. They focus on transforming clinical trials and healthcare delivery through innovative, connected, and scalable technologies and services. Their mission is to accelerate healthcare innovation and improve patient outcomes by integrating data, technology, and expertise.
Industries
Nr. of Employees
large (251-1000)
DrugDev
Wayne, Pennsylvania, United States, North America
Patents
Products
Inspection-ready eTMF application
Web-based eTMF providing dashboards for TMF health, guided study setup, document QC workflows, audit trails, metadata extraction, and support for standard TMF exchange formats.
Streamlined eTMF SaaS package
A lower-cost, accelerated eTMF SaaS offering with implementation accelerators, validator resources, SOP templates, and optional expert operations support.
Patient engagement platform (eConsent, eCOA, RTSM, device integration)
A suite of interoperable patient-facing applications for electronic consent, electronic clinical outcome assessments, randomization/supply management, and connected device data ingestion.
Investigator site portal (modular site platform)
Modular site portal delivered as SaaS that centralizes document exchange, study start-up workflows, learning management, safety communications, and site engagement tools.
Site SSO aggregator and task management platform
Neutral, site-facing platform that aggregates multiple clinical applications, provides single sign-on, task prioritization, and personalized content to reduce login fragmentation and prioritize site work.
Searchable investigator and site databank
Cloud-based repository offering curated and standardized investigator/site records, performance metrics, and unique identifier mapping to inform feasibility and site selection.
Inspection-ready eTMF application
Web-based eTMF providing dashboards for TMF health, guided study setup, document QC workflows, audit trails, metadata extraction, and support for standard TMF exchange formats.
Streamlined eTMF SaaS package
A lower-cost, accelerated eTMF SaaS offering with implementation accelerators, validator resources, SOP templates, and optional expert operations support.
Patient engagement platform (eConsent, eCOA, RTSM, device integration)
A suite of interoperable patient-facing applications for electronic consent, electronic clinical outcome assessments, randomization/supply management, and connected device data ingestion.
Investigator site portal (modular site platform)
Modular site portal delivered as SaaS that centralizes document exchange, study start-up workflows, learning management, safety communications, and site engagement tools.
Site SSO aggregator and task management platform
Neutral, site-facing platform that aggregates multiple clinical applications, provides single sign-on, task prioritization, and personalized content to reduce login fragmentation and prioritize site work.
Searchable investigator and site databank
Cloud-based repository offering curated and standardized investigator/site records, performance metrics, and unique identifier mapping to inform feasibility and site selection.
Services
Operational support for TMF workflows including scanning, document ingestion, QC, metadata curation, inspection preparation, and long-term archiving.
Technical integration, partner onboarding, and neutral aggregation services to connect third-party clinical applications into a single site-facing platform with SSO and task management.
Access to a curated investigator/site databank combined with advisory services to automate feasibility surveys, score sites, and inform protocol and site selection decisions.
Global payment orchestration, multi-currency processing, participant stipend disbursement, site invoicing, and forecasting to ensure timely, compliant payments.
Data ingestion, harmonization, analytics deployment, model development and operationalization, including conversational AI and intelligent applications for operational automation.
Device strategy, unbiased device selection, device provisioning, data capture validation, and operational support to integrate wearable and at-home device data into trial workflows.
Operational support for TMF workflows including scanning, document ingestion, QC, metadata curation, inspection preparation, and long-term archiving.
Technical integration, partner onboarding, and neutral aggregation services to connect third-party clinical applications into a single site-facing platform with SSO and task management.
Access to a curated investigator/site databank combined with advisory services to automate feasibility surveys, score sites, and inform protocol and site selection decisions.
Global payment orchestration, multi-currency processing, participant stipend disbursement, site invoicing, and forecasting to ensure timely, compliant payments.
Data ingestion, harmonization, analytics deployment, model development and operationalization, including conversational AI and intelligent applications for operational automation.
Device strategy, unbiased device selection, device provisioning, data capture validation, and operational support to integrate wearable and at-home device data into trial workflows.
Expertise Areas
- Clinical trial operations and site activation
- Site engagement and portal platforms
- Feasibility and investigator/site selection
- Enrollment forecasting and optimization
Key Technologies
- Cloud-based SaaS platforms
- AI/ML and generative AI
- Conversational AI for data querying
- Clinical data harmonization and ETL
News & Updates
The 2023 Everest Group Life Sciences Operations PEAK Matrix® Assessment named IQVIA a 'Leader' and positioned highest among surveyed companies.
IQVIA Technologies describes the role of AI in clinical trials to simplify data complexity and enhance decision-making.
The 2023 Everest Group Life Sciences Operations PEAK Matrix® Assessment evaluated 28 companies, placing IQVIA as a 'Leader' and highest-ranked.
The 2023 Everest Group Life Sciences Operations PEAK Matrix® Assessment named IQVIA a 'Leader' and positioned highest among surveyed companies.
IQVIA Technologies describes the role of AI in clinical trials to simplify data complexity and enhance decision-making.
The 2023 Everest Group Life Sciences Operations PEAK Matrix® Assessment evaluated 28 companies, placing IQVIA as a 'Leader' and highest-ranked.